Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The OxAAA Study has been awarded a Novel and Emerging Technologies Grant worth £247,685 from Heart Research UK to develop a novel treatment for pseudoaneurysm in the groin.

Professor Ashok Handa, Professor Eleanor Stride and Dr Regent Lee from the University of Oxford. © NDS
From L-R: Dr Regent Lee, Professor Eleanor Stride and Professor Ashok Handa.

The use of ‘keyhole’ procedures to treat heart or artery problems has increased over the years, but a potential complication is bleeding from the hole to form a ‘pseudoaneurysm’ in the groin.

Professor Ashok Handa and Dr Regent Lee from the Nuffield Department of Surgical Sciences, along with Professor Eleanor Stride from the Institute of Biomedical Engineering, aim to develop a new treatment for patients who experience this complication.

The research team will develop a medication which can be injected into the pseudoaneurysm to make the bleeding stop. This new treatment would eliminate the complication or traditional treatment methods and avoid open surgical repair. This is particularly important in vulnerable patients with multiple medical problems.

Read more on the Heart Research UK website.

For further information about the OxAAA Study visit the group page.

Similar stories

New reporting guidelines to bridge the gap from development to implementation in clinical artificial intelligence

Innovation Research

In a correspondence to Nature Medicine, a team of Oxford-led academics describe upcoming new guidelines to improve the reporting of early clinical stage (or first-with-human) evaluation of decision support systems driven by artificial intelligence.

NDS project awarded Public Engagement Seed Funding 2020-21

Awards and appointments Public engagement

Seven projects from the Medical Sciences Division, including a project from the Nuffield Department of Surgical Sciences, have received funding in the 2020-21 round of the Public Engagement with Research Seed Fund for innovative projects to engage the public with medical research.

Cochrane ENT awarded NIHR funding for COVID-19 project

Awards and appointments Coronavirus COVID-19 Research

Cochrane ENT at the Nuffield Department of Surgical Sciences has been awarded funding by the National Institute for Health Research (NIHR) to complete a suite of living systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell after COVID-19 infection.

First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy

Coronavirus COVID-19 Publication Research

Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.

Applications for Oxford-Wolfson-Marriott-Patel Scholarship now open

Awards and appointments Department Research

The Nuffield Department of Surgical Sciences (NDS) are pleased to confirm that one scholarship will be available for Home (UK) and Republic of Ireland (ROI) candidates for the DPhil in Surgical Sciences, starting in Michaelmas Term 2021.

Oxford University breakthrough on global COVID-19 vaccine

Coronavirus COVID-19 Research

The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.